T. Rowe Price Exchange-Traded Funds, Inc. - TMED
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | History | Reduced | 27,601 | 820 | 0.0% | 0.0% | 1 | -2,173 | -7.3% | Q4 2025 | Feb 17, 2026 |
| FLOW TRADERS U.S. LLC | History | Reduced | 23,188 | 689 | 0.02% | 0.05% | 2 | -24,008 | -50.87% | Q4 2025 | Feb 13, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | History | New | 11,035 | 328 | 0.0% | — | 3 | +11,035 | New | Q4 2025 | Feb 12, 2026 |
| Essex Financial Services, Inc. | History | No change | 9,100 | 270 | 0.02% | 0.01% | 4 | 0 | 0.0% | Q4 2025 | Feb 10, 2026 |
| UBS Group AG | History | New | 52 | 1 | 0.0% | — | 5 | +52 | New | Q4 2025 | Jan 29, 2026 |